Related Experiment Video
Updated: Aug 17, 2026

Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
Transplantation of kidneys from expanded criteria donors
L E Ratner1, E Kraus, T Magnuson
1Department of Surgery, Johns Hopkins Bayview Medical Center, Baltimore, Maryland 21224, USA.
Background:
The critical shortage of organs for transplantation has resulted in a controversial expansion of the criteria used to define a suitable cadaveric organ donor. The shortage of kidneys has a particularly hard impact on those patients on the waiting list who have uncommon major histocompatibility antigens or who are highly immunized.
Methods:
To determine outcomes between patients receiving grafts from expanded criteria donors (ECDs) and others, a retrospective review of 105 consecutive kidney transplantations performed at a single institution during a 3 1/2 year period was conducted. A total of 44 (41.9%) patients received kidneys from ECDs, 45 (42.9%) from conventional cadaveric donors, and 16 (15.2%) from live donors. All patients were treated by the same physicians and received either triple or quadruple sequential immunosuppressive therapy. In general, high risk recipients did not receive kidneys from ECDs.
Results:
Actuarial graft survival, incidence of delayed function, length of stay, and hospital charges were not significantly different between the ECD and conventional cadaveric donor groups of recipients. A higher incidence of urinary complications occurred in the ECD group (p=0.03). This incidence was noted primarily in the recipients of kidneys from donors 5 years of age or younger. However, no allografts were lost as a result of urinary complications. ECD kidneys that were imported from outside the local catchment area accounted for approximately 25% of all cadaveric transplantations performed.
Conclusions:
With appropriate selection of organs from ECDs, acceptable results can be obtained. ECD organs can serve to partially alleviate the extreme organ shortage. These organs should be procured and made available to those centers willing to use them.
Insights
Expanded criteria donors (ECDs) offer a viable solution to the critical organ shortage. Kidneys from ECDs demonstrate comparable graft survival to conventional donors, partially alleviating transplant waiting lists.
Area of Science:
- Nephrology
- Transplantation Immunology
- Organ Donation
Background:
- Critical organ shortage necessitates expanded criteria for cadaveric donors.
- Kidney transplant waiting lists are particularly impacted by donor scarcity, especially for patients with specific antigen profiles.
Purpose of the Study:
- To compare outcomes of kidney transplantation using grafts from expanded criteria donors (ECDs) versus conventional donors.
- To assess the impact of ECD utilization on graft survival, graft function, and patient recovery.
Main Methods:
- Retrospective review of 105 kidney transplantations over 3.5 years.
- Categorization of donors into ECD, conventional cadaveric, and live donors.
- Standardized immunosuppressive therapy (triple or quadruple) for all recipients.
Main Results:
- No significant differences in graft survival, delayed graft function, length of stay, or hospital charges between ECD and conventional donor groups.
- Increased urinary complications observed in the ECD group, primarily in recipients of very young donors (<5 years), without allograft loss.
- ECD kidneys constituted approximately 25% of all cadaveric transplantations.
Conclusions:
- Appropriate selection of ECDs yields acceptable kidney transplant outcomes.
- ECD organs can help mitigate the severe organ shortage.
- Encouraging procurement and utilization of ECD organs by transplant centers.
Related Concept Videos
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

